CompletedNot Applicable

The Post-Vitrectomy Lenstatin™ Study

United States20 participantsStarted 2014-06

Plain-language summary

To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults over the age of 18 * Post pars plana vitrectomy surgery Exclusion Criteria: * Pediatric patients under the age of 18 * Pregnant women * Hypersensitivity to any of the ingredients in Lenstatin

What they're measuring

Pentacam Nuclear Density Measurements

Timeframe: (6) months

Trial details

NCT IDNCT02131194

SponsorLenstatin LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Cataract, Nuclear Progressive trials